Artificial intelligence (AI) supported patient self-care and consultation in chronic heart failure: A paradigm shift from reactive to predictive, preventive and personalized care
Due to older adults and enhanced care of underlying issues and one of the most difficult persistent illnesses with a high prevalence it is also known as heart failure and enlarged heart failure. Heart failure is a chronic disorder in which the heart’s ability to pump blood (systolic) or fill blood (...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Tagungsbericht |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Due to older adults and enhanced care of underlying issues and one of the most difficult persistent illnesses with a high prevalence it is also known as heart failure and enlarged heart failure. Heart failure is a chronic disorder in which the heart’s ability to pump blood (systolic) or fill blood (diastolic) is impaired. adequately. By 2025, it is believed that prevalence may have risen to 3% of the population in countries in the West. It is the leading reason for hospitalization in patients 65 years of age or more mature resulting in significant cost and tremendous societal influence. The present "one-size-fits-all" strategy for controlling HF does not produce the finest outcomes for every individual patient. These findings pose can immediately indicate the danger and any harm to the effective therapy of HF patients. An unconventional strategy from a new perspective on consultation is needed. We suggest a revolutionary paradigm to personalized, preventative, and predictive medicines, where an individual are truly concerned. The final results are projected to be positive advance and enhance self-care, where humans, in principle, to do routine medical checkup without the aid of practitioners so that the latter can focus on challenging diseases. This new viewpoint on consultation. To ensure the long-term sustainability of high-quality HF treatment, considerably lower costs per patient must be achieved while outcomes are improved. |
---|---|
ISSN: | 0094-243X 1551-7616 |
DOI: | 10.1063/5.0240419 |